The theme of this book is that the modern era in Psychiatry, and specifically in Psychopharmacology, the 'Anti-Depressant Era,' has brought with with it not just a raft of new drugs - anti-depressant, anti-psychotic, anxiolytic etc - but also a raft of new industrial practices also.
Key to understanding this book is the line 'Is the standardisation that is appearing in Psychiatry the result of scientific progress or a consequence of an industrial progress?' It is a very good question, one that Healy leaves the reader to answer for his or herself.
In a similiar fashion to the way some complain about the 'military-industrial complex,' the proposition that the growth of the military in America and the massive amounts of money pumped into it necessitates the need for war likewise does Healy seem to be proposing that the growth of the Pharmaceutical industry and the massive growth in their profits necessitates the need for new 'illness's.' The best example of same being at the start of the era when, in order to to market Amitriptryline, Merck marketed the concept of depression by buying and distributing copies of Frank Ayd's 'Recognising the Depressed Patient,' which concentrated on recognizing and treating depression in general medical settings.
The ever-increasing 'specificity' (its ability to work on specific chemicals in the brain) of the new drugs being brought into the marketplace, is questioned likewise the expansion in the number of categories of mental illness to match the ever increasing specificity of the new therapeutic compounds.
David Healy is by far and away the best historian of Psychopharmacology and because, in the modern era, the history of Psychopharmacology IS the history of Psychiatry, he is the best historian of Psychiatry in the modern era too. Anyone interested in Psychiatry should read this and then read all his other books.